* Novartis AG reported quarterly adjusted earnings of $1.52 per share for the quarter ended in December. The mean expectation of nine analysts for the quarter was for earnings of $1.40 per share. *
NAIROBI (Reuters) - Improved security in Ethiopia's Tigray region since a November ceasefire has allowed aid to reach some previously inaccessible areas, but humanitarian needs remain urgent, the
By Ludwig Burger BASEL (Reuters) - Novartis on Wednesday predicted that core operating income would grow in a "mid single digit" percentage range in 2023 following stagnation last year, as the Swiss
Jan 31 (Reuters) - RMH Holdings Ltd: * HE WEIQING HAS RESIGNED AS CHAIRMAN * LIU FEI APPOINTED AS AN INDEPENDENT NON- EXECUTIVE DIRECTOR * YANG ZHANGXIN APPOINTED AS CHAIRMAN * YANG ZHANGXIN HAS BEEN
Jan 31 (Reuters) - Lunit Inc: * GUARDANT HEALTH TO INTEGRATE LUNIT'S AI-BASED SCORING ALGORITHM FOR PD-L1 INTO ITS PORTFOLIO TO ENHANCE CANCER BIOMARKER DETECTION Source text for Eikon: Further
FRANKFURT, Jan 31 (Reuters) - A top-10 shareholder of Bayer on Tuesday called on the group's supervisory board head to replace chief executive Werner Baumann quickly, adding to investor pressure to
Jan 31 (Reuters) - ALIMTIAZ INVESTMENT GROUP: * Q4 NET LOSS ATTRIBUTABLE 3.6 MILLION DINARS VERSUS LOSS OF 888,099 DINARS YEAR AGO * Q4 TOTAL OPERATING REVENUE 5.5 MILLION DINARS VERSUS 6 MILLION
Jan 31 (Reuters) - ADVANCED TECHNOLOGY: * SIGNS 20 MILLION DINARS CREDIT FACILITIES AGREEMENT WITH A LOCAL BANK Further company coverage:
Jan 31 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Sixt SE, Team17 Group Plc and Ubisoft on Tuesday. HIGHLIGHTS * Berkeley Group :
By Patrick Wingrove Jan 31 (Reuters) - U.S. patients will finally get access to cheaper versions of AbbVie Inc’s blockbuster arthritis drug Humira this year, but the cost savings are expected to be